SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-187279
Filing Date
2013-04-30
Accepted
2013-04-30 16:15:59
Documents
4
Period of Report
2013-06-10
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d527708ddef14a.htm DEF 14A 375229
2 GRAPHIC g527708g15f58.jpg GRAPHIC 177515
3 GRAPHIC g527708g32p59.jpg GRAPHIC 171318
4 GRAPHIC g527708g46e70.jpg GRAPHIC 7456
  Complete submission text file 0001193125-13-187279.txt   867630
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35670 | Film No.: 13797675
SIC: 2834 Pharmaceutical Preparations